Your browser doesn't support javascript.
loading
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Gounder, Mrinal M; Razak, Albiruni Abdul; Somaiah, Neeta; Chawla, Sant; Martin-Broto, Javier; Grignani, Giovanni; Schuetze, Scott M; Vincenzi, Bruno; Wagner, Andrew J; Chmielowski, Bartosz; Jones, Robin L; Riedel, Richard F; Stacchiotti, Silvia; Loggers, Elizabeth T; Ganjoo, Kristen N; Le Cesne, Axel; Italiano, Antoine; Garcia Del Muro, Xavier; Burgess, Melissa; Piperno-Neumann, Sophie; Ryan, Christopher; Mulcahy, Mary F; Forscher, Charles; Penel, Nicolas; Okuno, Scott; Elias, Anthony; Hartner, Lee; Philip, Tony; Alcindor, Thierry; Kasper, Bernd; Reichardt, Peter; Lapeire, Lore; Blay, Jean-Yves; Chevreau, Christine; Valverde Morales, Claudia Maria; Schwartz, Gary K; Chen, James L; Deshpande, Hari; Davis, Elizabeth J; Nicholas, Garth; Gröschel, Stefan; Hatcher, Helen; Duffaud, Florence; Herráez, Antonio Casado; Beveridge, Roberto Diaz; Badalamenti, Giuseppe; Eriksson, Mikael; Meyer, Christian; von Mehren, Margaret; Van Tine, Brian A.
Affiliation
  • Gounder MM; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.
  • Razak AA; Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Somaiah N; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chawla S; Sarcoma Oncology Center, Santa Monica, CA.
  • Martin-Broto J; Fundacion Jimenez Diaz University Hospital, Madrid, Madrid, Spain.
  • Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Schuetze SM; University of Michigan, Ann Arbor, MI.
  • Vincenzi B; Policlinico Universitario Campus Bio-Medico, Roma, Italy.
  • Wagner AJ; Dana-Farber Cancer Institute, Boston, MA.
  • Chmielowski B; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA.
  • Jones RL; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.
  • Riedel RF; Duke Cancer Institute, Durham, NC.
  • Stacchiotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Loggers ET; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Ganjoo KN; Stanford Cancer Institute, Stanford, CA.
  • Le Cesne A; Institut Gustave Roussy, Villejuif, France.
  • Italiano A; Institut Bergonié, Bordeaux, France.
  • Garcia Del Muro X; Catalan Institute of Oncology, IDIBELL, University of Barcelona, Barcelona, Spain.
  • Burgess M; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA.
  • Piperno-Neumann S; Institut Curie, Paris, France.
  • Ryan C; Oregon Health & Science University, Portland, OR.
  • Mulcahy MF; The Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
  • Forscher C; Cedars-Sinai Medical Center, West Hollywood, CA.
  • Penel N; Centre Oscar Lambret and Lille University, Lille, France.
  • Okuno S; Mayo Clinic Rochester, Rochester, MN.
  • Elias A; University of Colorado-Denver, Aurora, CO.
  • Hartner L; University of Pennsylvania, Philadelphia, PA.
  • Philip T; Northwell Health Physician Partners, New Hyde Park, NY.
  • Alcindor T; McGill University Health Centre, Montreal, Quebec, Canada.
  • Kasper B; Mannheim University Medical Center, Mannheim, Germany.
  • Reichardt P; Helios Hospital Berlin-Buch, Berlin, Germany.
  • Lapeire L; University Hospital Gent, Gent, Belgium.
  • Blay JY; Centre Leon Berard, Lyon, France.
  • Chevreau C; Institut Claudius Regaud-IUCT-O, Toulouse, France.
  • Valverde Morales CM; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Schwartz GK; Columbia University Irving Medical Center, New York, NY.
  • Chen JL; The Ohio State James Cancer Center, Columbus, OH.
  • Deshpande H; Yale Cancer Center, New Haven, CT.
  • Davis EJ; The Vanderbilt Clinic, Nashville, TN.
  • Nicholas G; Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada.
  • Gröschel S; National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Heidelberg, Germany.
  • Hatcher H; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Duffaud F; La Timone University Hospital Center and Aix-Marseille University, Marseille, France.
  • Herráez AC; Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Beveridge RD; Hospital La Fe Valencia, Valencia, Spain.
  • Badalamenti G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Eriksson M; Skane University Hospital, Lund, Sweden.
  • Meyer C; Johns Hopkins, Baltimore, MD.
  • von Mehren M; Fox Chase Cancer Center, Philadelphia, PA.
  • Van Tine BA; Washington University School of Medicine, St Louis, MO.
J Clin Oncol ; 40(22): 2479-2490, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35394800
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Hydrazines / Liposarcoma Type of study: Clinical_trials / Prognostic_studies Limits: Child / Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Hydrazines / Liposarcoma Type of study: Clinical_trials / Prognostic_studies Limits: Child / Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Country of publication: